Sharat Industries Ltd (SHINDL)
🎯 Key Takeaways
- Sharat Industries Ltd is transitioning from a domestically focused FMCG player to an export-driven growth enterprise, with strategic emphasis on geographic diversification and value-added product development. Management is actively pursuing international market penetration, particularly in the US and EU, supported by tariff reductions and targeted partnerships, while expanding into emerging categories like insect protein feed and renewable energy.
- Revenue grew 2.6% QoQ to ₹120 in Q1FY27.
- ⚠️ 1) Geopolitical volatility in key export markets like the Middle East continues to disrupt logistics and inventory planning, as evidenced by recent re
- Market Cap
- ₹625
- P/E Ratio
- 37.3
- P/B Ratio
- 4.05
- ROE
- 10.9%
- ROCE
- 12.7%
- Debt/Equity
- 0.81
- Promoter
- 45.0%
📖 The Story
Sharat Industries Ltd is transitioning from a domestically focused FMCG player to an export-driven growth enterprise, with strategic emphasis on geographic diversification and value-added product development. Management is actively pursuing international market penetration, particularly in the US and EU, supported by tariff reductions and targeted partnerships, while expanding into emerging categories like insect protein feed and renewable energy. The company is in a deliberate investment phase, leveraging operational scale and margin recovery to build export infrastructure, though profitability remains sensitive to geopolitical volatility and input cost pressures.
📰 What's Happening
In the March 2026 quarter, Sharat Industries reported a 38% YoY revenue increase to Rs 524.7 crore for FY26, with PAT surging 60% to Rs 15.90 crore, driven by export growth of 23% despite Middle East conflict disruptions. Management highlighted successful rerouting of 20 containers due to regional instability, which increased logistics costs and inventory levels, while US tariff relief reduced duties from 50% to 10% in February 2026. Key initiatives include commissioning a 1MW solar project for captive consumption, scaling insect protein feed R&D, and targeting Rs 1,000 crore in export revenue by FY28. Domestic expansion plans involve partnerships with Hyperpure and leveraging government cold chain subsidies to strengthen market presence.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 150 | 143 | 117 | 120 |
| Operating Profit | 11 | 8 | 2 | 12 |
| OPM % | 7.2% | 5.8% | 1.9% | 9.7% |
| Net Profit | 6 | 5 | 0 | 6 |
| EPS | ₹1.46 | ₹1.21 | ₹0.01 | ₹1.60 |
The company's quarterly revenue trajectory shows a clear inflection point: after peaking at Rs 150 crore in September 2025, revenue dipped to Rs 143 crore in December 2025 and Rs 117 crore in March 2026, before rising to Rs 120 crore in June 2026. This pattern reflects temporary softness in export demand and operational disruptions, but the sequential improvement in June 2026 aligns with management's narrative of export recovery and margin stabilization. Operating profit margins improved from 1.9% in March 2026 to 9.7% in June 2026, indicating that cost controls and scale benefits are beginning to materialize despite earlier headwinds from logistics and input volatility.
🔮 Management Outlook & What's Next
Management has provided a forward-looking roadmap targeting Rs 1,000 crore in export revenue by FY28, underpinned by successful US market entry following tariff reductions, expansion into EU and other regions, and scaling of high-margin product lines such as insect protein feed. The company is also advancing a 1MW solar project to reduce energy costs and improve sustainability credentials, while exploring domestic growth through strategic partnerships and government-backed cold chain initiatives. These moves signal a deliberate shift toward capital-light, export-oriented growth with an emphasis on margin accretion and supply chain resilience.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 38 | 24 | 39 | 39 |
| Reserves | 99 | 79 | 115 | 112 |
| Borrowings | 113 | 108 | 126 | 120 |
| Total Liabilities | 279 | 234 | 316 | 315 |
| Fixed Assets | 43 | 45 | 46 | 41 |
| Investments | 0 | 0 | 0 | 0 |
| Total Assets | 279 | 234 | 316 | 315 |
The balance sheet shows a stable capital structure with total assets growing from Rs 279 crore in March 2025 to Rs 316 crore in March 2026, driven by incremental asset creation likely tied to the solar project and export infrastructure. Borrowings increased modestly from Rs 113 crore to Rs 126 crore over the same period, suggesting ongoing but controlled leverage to fund growth initiatives. Equity and reserves have risen steadily, indicating retained earnings are being reinvested rather than distributed, supporting long-term capital formation without aggressive dilution or debt escalation.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 | Mar 2026 |
|---|---|---|
| Operating | -26 | +1 |
| Investing | -2 | -9 |
| Financing | +48 | +3 |
| Net Cash Flow | +20 | -5 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 44.0% | 44.4% | 45.0% | 45.0% |
| FII | 0.2% | 0.0% | 0.0% | 0.1% |
| DII | 0.2% | 0.2% | 0.6% | 0.6% |
| Public | 44.3% | 44.4% | 44.9% | 43.9% |
| # Shareholders | 38,032 | 37,477 | 37,448 | 37,282 |
Promoter holding has remained stable around 45%, with no significant dilution or sale activity observed across recent quarters. Institutional interest (FII and DII) remains minimal, with FII holding at 0.07% in Q1FY27 and no exposure reported in Q4FY26, while DII holds a marginal 0.59%. The broad retail base (over 37,000 shareholders) suggests limited institutional conviction, though the stable promoter stake may signal confidence in the long-term vision. The lack of foreign institutional accumulation could reflect cautious sentiment despite improving fundamentals.
⚖️ Peer Comparison — FMCG
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| HINDUNILVR | 4.39 L Cr | 29.3 | 29.8% | — | 0.00 |
| ITC | 3.32 L Cr | 16.7 | 36.0% | — | 0.03 |
| NESTLEIND | 2.58 L Cr | 67.6 | 99.2% | — | 0.00 |
| VBL | 1.45 L Cr | 43.0 | 21.5% | — | 0.10 |
| LENSKART | 1.17 L Cr | 176.0 | 11.9% | — | 0.03 |
| BRITANNIA | 1.16 L Cr | 44.7 | 54.1% | — | 0.27 |
| MARICO | 1.03 L Cr | 54.4 | 54.2% | — | 0.08 |
| TATACONSUM | 95,699 | 58.5 | 10.2% | — | 0.10 |
| GODREJCP | 87,631 | 45.8 | 17.8% | — | 0.33 |
| DABUR | 67,419 | 34.2 | 21.3% | — | 0.09 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) Geopolitical volatility in key export markets like the Middle East continues to disrupt logistics and inventory planning, as evidenced by recent rerouting and cost inflation. 2) Raw material price volatility poses a margin risk, particularly given the company's exposure to commodity-linked inputs in its FMCG and feed segments. 3) Execution risk around the insect protein feed R&D and renewable energy projects remains high, with commercial viability yet to be proven at scale. 4) Dependence on a few high-growth export markets introduces concentration risk, especially as US tariff benefits are time-bound and subject to policy shifts.
📋 Recent Filings
- Announcement2026-09-28Sharat Industries Ltd announced that its trading window will close on 1 October 2026 for all insiders, including directors, promoters, officers, and d…
- 🔴 annual report2026-09-07Sharat Industries held its 36th AGM on 30 September 2026, approving FY26 results with revenue of **₹524.7 crores** (+38%), PAT of **₹15.9 crores** (+6…
- 🟡 Board Meeting2026-09-07Sharat Industries Ltd announced that its 36th Annual General Meeting will be held on 23 September 2026, with the Register of Members and Share Transfe…
- 🔴 annual report2026-09-07Sharat Industries reported FY26 revenue of **₹524.7 Cr** (+38%) and profit after tax of **₹15.9 Cr** (+60%), with EPS at **₹4.1** and ROE rising to 10…
- 🟡 concall transcript2026-03-31Sharat Industries reported FY26 revenue of Rs 524.7 crore, up 38% YoY, with PAT rising 60% to Rs 15.90 crore. Export revenue grew 23% despite Middle E…
🧠 Analyst's Read
Sharat Industries is executing a clear, capital-intensive transition toward export-led growth with early signs of margin recovery and strategic diversification. Investors should monitor execution progress on export targets, US market traction, and the commercial rollout of insect protein and solar initiatives, as these will determine whether the current investment phase delivers sustainable profitability.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when SHINDL files new disclosures
Track SHINDL filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SHINDL — FreeFree account · 2 AI queries/day